MONTREAL, Dec. 8 /CNW Telbec/ - Biophage Pharma Inc. (TSX.V: BUG) today announced that it is developing a novel platform for the selective isolation and concentration of bacteria based on the unique properties of natural phages from the proprietary phage bank of Biophage. The BacTrapping(R) system will be used for the selective capture of bacteria in a contaminated sample. This system can be used as a stand-alone system or in tandem with our PDS(R) Biosensor.
